Barrow, Hanley, Mewhinney & Strauss’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5K Hold
245
﹤0.01% 303
2026
Q1
$4.95K Sell
245
-308
-56% -$6.85K ﹤0.01% 273
2025
Q4
$10.6K Hold
553
﹤0.01% 212
2025
Q3
$13.3K Sell
553
-288
-34% -$6.73K ﹤0.01% 189
2025
Q2
$16.4K Sell
841
-27
-3% -$399 ﹤0.01% 165
2025
Q1
$11.2K Buy
868
+76
+10% +$1.22K ﹤0.01% 209
2024
Q4
$13.6K Sell
792
-1,607,045
-100% -$32.1M ﹤0.01% 206
2024
Q3
$36.3M Sell
1,607,837
-8,620
-0.5% -$197K 0.12% 120
2024
Q2
$39.9M Buy
1,616,457
+17,833
+1% +$506K 0.14% 117
2024
Q1
$52.6M Sell
1,598,624
-12,198
-0.8% -$415K 0.18% 101
2023
Q4
$58.6M Sell
1,610,822
-20,182
-1% -$693K 0.21% 96
2023
Q3
$59.9M Buy
1,631,004
+30,506
+2% +$1.22M 0.23% 84
2023
Q2
$61.3M Buy
1,600,498
+12,856
+0.8% +$475K 0.23% 82
2023
Q1
$65M Buy
1,587,642
+32,459
+2% +$1.36M 0.25% 80
2022
Q4
$53.9M Buy
1,555,183
+44,207
+3% +$1.55M 0.2% 86
2022
Q3
$41.9M Sell
1,510,976
-40,631
-3% -$1.32M 0.17% 94
2022
Q2
$46M Sell
1,551,607
-505,194
-25% -$17M 0.17% 87
2022
Q1
$83.9M Sell
2,056,801
-32,607
-2% -$1.4M 0.27% 74
2021
Q4
$100M Sell
2,089,408
-49,629
-2% -$2.23M 0.32% 70
2021
Q3
$88.7M Sell
2,139,037
-24,340
-1% -$970K 0.29% 75
2021
Q2
$97.8M Sell
2,163,377
-157,517
-7% -$7.37M 0.31% 72
2021
Q1
$103M Sell
2,320,894
-224,341
-9% -$8.47M 0.33% 75
2020
Q4
$88.5M Sell
2,545,235
-1,562,326
-38% -$44M 0.31% 82
2020
Q3
$71.2M Sell
4,107,561
-133,957
-3% -$2.33M 0.27% 78
2020
Q2
$69.6M Sell
4,241,518
-92,313
-2% -$1.4M 0.27% 78
2020
Q1
$39.3M Buy
4,333,831
+1,540,161
+55% +$31M 0.18% 93
2019
Q4
$59.4M Buy
2,793,670
+454,929
+19% +$10.1M 0.19% 96
2019
Q3
$53.7M Buy
2,338,741
+53,478
+2% +$1.22M 0.11% 112
2019
Q2
$55.5M Buy
+2,285,263
New +$47M 0.1% 118
2019
Q1
Sell
-4,862,744
Closed -$73.2M 341
2018
Q4
$73.2M Sell
4,862,744
-5,247,683
-52% -$136M 0.14% 97
2018
Q3
$397M Buy
10,110,427
+112,835
+1% +$5.08M 0.63% 44
2018
Q2
$492M Buy
9,997,592
+656,040
+7% +$37.2M 0.79% 40
2018
Q1
$558M Buy
9,341,552
+3,394,306
+57% +$226M 0.89% 37
2017
Q4
$468M Sell
5,947,246
-225,412
-4% -$18.2M 0.7% 42
2017
Q3
$518M Buy
6,172,658
+2,521,171
+69% +$179M 0.78% 39
2017
Q2
$239M Buy
3,651,487
+427,841
+13% +$29.1M 0.36% 64
2017
Q1
$234M Sell
3,223,646
-116,758
-3% -$7.67M 0.35% 65
2016
Q4
$196M Buy
+3,340,404
New +$176M 0.29% 74

Other funds holding ADNT

Barrow, Hanley, Mewhinney & Strauss's ADNT Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its Adient (ADNT) position steady in Q2 2026 at 245 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ADNT in Q4 2016 and has held it in 38 quarters since. The position peaked at $558M in Q1 2018. 312 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 245 shares of Adient worth $4.5K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its Adient share count unchanged in Q2 2026.
  • Adient made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #303 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Adient in Q4 2016 and has held it in 38 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Adient position peaked at $558M in Q1 2018.
  • 312 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.